HomeAdvocacy Advocacy News

Advocacy News

Displaying results 1-10 (of 143)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >| 

Lawsuits Target Pharmacies Over Prescription Drug Costs

As patients, providers, and politicians alike look for answers to the soaring cost of prescription drugs, some patients have taken matters into their own hands. A series of lawsuits have popped up across the country targeting pharmacies and their relationship to pharmacy benefit managers.

READ MORE

FDA Creates Pathway for Interchangeable Biologics

The FDA has released its highly anticipated but long delayed interchangeability guidelines, and the market seems primed for new developments.

READ MORE

AMA House of Delegates Policy Update

At the AMA’s Annual House of Delegate Meeting, hundreds of medical professionals gathered to discuss and address a wide range of healthcare issues, including the opioid crisis, physician burnout, regulating physician assistants and advanced practice registered nurses, and of course, healthcare reform and drug pricing.

READ MORE

States move to enforce FDA’s Biosimilar Interchangeability Guidelines from the Ground Up

The Food and Drug Administration’s guidelines for biosimilar interchangeability, released in January 2017, have come under renewed focus with concerns about patients being switched onto biosimilars by insurers without consultation with their physicians.

READ MORE

California Takes Aim at Pharmacy Benefit Managers With Assembly Bill 315

California’s Assembly Bill 315, which takes aim at Pharmacy Benefit Managers (PBMs), recently cleared the Assembly floor, and is now headed to the Senate for consideration.

READ MORE

State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.

READ MORE

Senate HELP Committee Wades into Drug Prices Debate

Despite intractable differences between the parties on healthcare policy, the Senate’s Health, Education, Labor, and Pensions Committee (HELP) convened a hearing this week to frame future efforts in combating high drug prices.

READ MORE

The Atlantic Hosts Biosimilars Policy Roundtable.

The Atlantic recently concluded its policy roundtable on biosimilars June 7th, with the third and final installment titled: “The Next Drugs: An Atlantic Policy Update on Biosimilars.”

READ MORE

Leading Health Organizations Announce Launch of Alliance for Transparent & Affordable Prescriptions

Health leaders today announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.

READ MORE

Maryland Enacts Biosimilars Bill

Maryland became the 35th state to approve of regulations and access for biosimilar medicines.

READ MORE

Displaying results 1-10 (of 143)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|